Direct-Selling Sector Ad Claim Monitor Snares Supplement, Personal Care Product Firms
Executive Summary
A BBB National Programs, Inc. investigative unit tells FTC that Dose of Nature failed to respond to its request to support its CBD oil claims; Utah direct sellers Young Living and doTerra agree to pull or modify drug claims for their essential oil products; HempWorx relabels topical as cosmetic.
You may also be interested in...
Questions Sent To FTC On Supplement Direct Seller Wayal Health Science's Ad Claims
Utah firm failed to respond to Direct Selling Self-Regulatory Council requests for substantiation for ad claims for supplements made in social media posts including “helps fight cancer, depression, and attention-deficit hyperactivity disorder.”
Industry Self-Regulation Review Of Claims Smells Unfair To US Essential Oils Marketer DoTerra
“We firmly believe NAD misunderstood the law and applied the wrong legal standard” says Kirk Jowers, doTerra’s corporate relations chief. But the firm “has little recourse but to comply.”
Young Living Says Consumers Not Swayed By Claim But Expect Its Essential Oils Are ‘Therapeutic’
In NAD review on a challenge by S.C. Johnson, which markets Caldrea brand essentials oils, Young Living said because consumers are equally as likely to believe the products are therapeutic grade regardless of which image they saw in a survey demonstrates the claim doesn’t impact consumers’ perception of its products.